
Stratum Biosciences is a dermatology discovery company leveraging a proprietary AI platform and over 200,000 real tissue samples to accelerate development of novel active ingredients and formulations for cosmetic and pharmaceutical skin products. A resident company of Johnson and Johnson's JLABs incubator, Stratum is solving some of skin's toughest challenges for global brands with a pipeline of high-value IP targeting diverse needs from skin longevity to hyperpigmentation and eczema.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/27/26 | $2,000,000 | Seed |
Harvard Business School Angels Skin Angels | undisclosed |